"10.1371_journal.pone.0139431","plos one","2015-10-01T00:00:00Z","Jean Marie Cohen; Maria Laura Silva; Saverio Caini; Meral Ciblak; Anne Mosnier; Isabelle Daviaud; Gonçalo Matias; Selim Badur; Martine Valette; Vincent Enouf; John Paget; Douglas M Fleming; IBGP study team","Open Rome (Organize and Promote Epidemiological Network), Paris, France; Réseau des GROG, Paris, France; Istanbul University, Istanbul, Turkey; GlaxoSmithKline (GSK) Biologicals, Brussels, Belgium; Virology Department, National Influenza Center, Claude Bernard University Lyon 1, Lyon, France; Virology Department, Unit of Molecular Genetics of RNA viruses, National Influenza Center, Pasteur Institute, CNRS UMR3569, Université Paris Diderot Sorbonne Paris Cité, Paris, France; Netherlands Institute for Health Services research (NIVEL), Utrecht, The Netherlands; Royal College of General Practitioners, Surveillance and Research Unit, Birmingham, United Kingdom","Conceived and designed the experiments: JMC GM JP DMF. Performed the experiments: JMC MLS MC AM ID MV VE. Analyzed the data: JMC MLS AM ID. Contributed reagents/materials/analysis tools: MV VE MC SB. Wrote the paper: JMC SC AM ID JP DMF.","The authors have read the journal's policy and the authors of this manuscript have the following competing interests: M.L.S., S.C., M.C., S.B., M.V. and V.E. declare having no conflicts of interest. J.M.C. and A.M. declare having received support for travel to meetings (Roche) and their institutions received grants from the study sponsor and from several pharmaceutical companies (Roche, AstraZeneca, Sanofi Pasteur MSD, GSK, Mylan) on matters relating to influenza surveillance and to the burden of illness due to influenza and its prevention. I.D. declares her institutions received grants from the study sponsor and from several pharmaceutical companies (Roche, AstraZeneca, Sanofi Pasteur MSD, GSK, Mylan) on matters relating to influenza surveillance and to the burden of illness due to influenza and it's prevention. W.J.P. has served on an influenza advisory board for GSK. G.M. declares being employed by GlaxoSmithKline Vaccines which has financed the IBGP study. D.F. declares having received consultancy payments from Open Rome relating to the design analysis and reporting of this material and having provided advisory board consultancy services to several pharmaceutical companies on matters relating to the burden of illness due to influenza and its prevention. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.","2015","10","Jean Marie Cohen","JMC",13,TRUE,4,7,4,6,TRUE,TRUE,TRUE,1,"13",TRUE
